Mirum Pharmaceuticals, Inc.
MIRM · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $3,712,362 | $2,530,598 | $2,202,449 | $1,998,776 |
| - Cash | $282,021 | $228,122 | $211,822 | $222,503 |
| + Debt | $316,729 | $318,898 | $317,156 | $317,763 |
| Enterprise Value | $3,747,070 | $2,621,374 | $2,307,783 | $2,094,036 |
| Revenue | $133,010 | $127,785 | $111,585 | $99,414 |
| % Growth | 4.1% | 14.5% | 12.2% | – |
| Gross Profit | $107,473 | $104,364 | $88,567 | $76,634 |
| % Margin | 80.8% | 81.7% | 79.4% | 77.1% |
| EBITDA | $9,060 | $4,186 | -$4,000 | -$14,731 |
| % Margin | 6.8% | 3.3% | -3.6% | -14.8% |
| Net Income | $2,905 | -$5,861 | -$14,677 | -$23,790 |
| % Margin | 2.2% | -4.6% | -13.2% | -23.9% |
| EPS Diluted | 0.05 | -0.12 | -0.3 | -0.49 |
| % Growth | 141.7% | 60% | 38.8% | – |
| Operating Cash Flow | $39,681 | $12,040 | -$1,961 | -$5,068 |
| Capital Expenditures | -$187 | -$126 | -$41 | -$20 |
| Free Cash Flow | $39,494 | $11,914 | -$2,002 | -$5,088 |